Source: Colloids and Surfaces B: Biointerfaces. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, v. 141, p. 74-82, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2016.01.032. Acesso em: 05 out. 2024.APA
Eloy, J. O., Petrilli, R., Topan, J. F., Antonio, H. M. R., Barcellos, J. P. A., Chesca, D. L., et al. (2016). Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, 141, 74-82. doi:10.1016/j.colsurfb.2016.01.032NLM
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032Vancouver
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032